North America Epinephrine Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Epinephrine Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Epinephrine Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Epinephrine Market Regional Analysis

6.2 North America Epinephrine Market Revenue 2017-2027 (US$ Million)

6.3 North America Epinephrine Market Forecast Analysis

7. North America Epinephrine Market Analysis – by Product Type

7.1 Prefilled Syringes

7.1.1 Overview
7.1.2 Prefilled Syringes: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Auto-Injectors

7.2.1 Overview
7.2.2 Auto-Injectors: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Ampoules and Vials

7.3.1 Overview
7.3.2 Ampoules and Vials: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. North America Epinephrine Market Analysis – by Application

8.1 Anaphylaxis

8.1.1 Overview
8.1.2 Anaphylaxis: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Superficial Bleeding

8.2.1 Overview
8.2.2 Superficial Bleeding: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Respiratory Disorders

8.3.1 Overview
8.3.2 Respiratory Disorders: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Cardiac Arrest

8.4.1 Overview
8.4.2 Cardiac Arrest: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. North America Epinephrine Market Analysis – by Distribution Channel

9.1 Retail Pharmacies

9.1.1 Overview
9.1.2 Retail Pharmacies: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Hospital Pharmacies

9.2.1 Overview
9.2.2 Hospital Pharmacies: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Online Pharmacies

9.3.1 Overview
9.3.2 Online Pharmacies: North America Epinephrine Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. North America Epinephrine Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Epinephrine Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 North America Epinephrine Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 US: North America Epinephrine Market Breakdown, by Product Type
10.2.1.1.2 US: North America Epinephrine Market Breakdown, by Application
10.2.1.1.3 US: North America Epinephrine Market Breakdown, by Distribution Channel

10.2.1.2 Canada: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Canada: North America Epinephrine Market Breakdown, by Product Type
10.2.1.2.2 Canada: North America Epinephrine Market Breakdown, by Application
10.2.1.2.3 Canada: North America Epinephrine Market Breakdown, by Distribution Channel

10.2.1.3 Mexico : North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Mexico : North America Epinephrine Market Breakdown, by Product Type
10.2.1.3.2 Mexico : North America Epinephrine Market Breakdown, by Application
10.2.1.3.3 Mexico : North America Epinephrine Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Mylan N.V.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Teva Pharmaceuticals Ltd.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Amneal Pharmaceuticals LLC

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 ALK-Abelló A/S

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Abbott

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Kaleo, Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 BIOPROJET

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Medeca Pharma AB

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Novartis AG

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Erythpharm

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Epinephrine Market

Analysis and Forecasts by Product Type (Prefilled Syringes, Auto-Injectors, Ampoules and Vials); Application (Anaphylaxis, Superficial Bleeding, Respiratory Disorders, Cardiac Arrest); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); and Country